Carson Wealth (CWM LLC)’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.92M | Buy |
10,171
+5,071
| +99% | +$886K | 0.01% | 1215 |
|
|
2025
Q4 | $867K | Buy |
5,100
+870
| +21% | +$133K | ﹤0.01% | 1582 |
|
|
2025
Q3 | $558K | Buy |
4,230
+490
| +13% | +$58.8K | ﹤0.01% | 1724 |
|
|
2025
Q2 | $397K | Buy |
3,740
+2,481
| +197% | +$270K | ﹤0.01% | 1700 |
|
|
2025
Q1 | $156K | Buy |
1,259
+453
| +56% | +$59.1K | ﹤0.01% | 2084 |
|
|
2024
Q4 | $99K | Buy |
806
+132
| +20% | +$15.6K | ﹤0.01% | 2289 |
|
|
2024
Q3 | $75K | Buy |
674
+62
| +10% | +$6.79K | ﹤0.01% | 2376 |
|
|
2024
Q2 | $65K | Sell |
612
-686
| -53% | -$75.4K | ﹤0.01% | 2282 |
|
|
2024
Q1 | $156K | Buy |
1,298
+681
| +110% | +$83.4K | ﹤0.01% | 1637 |
|
|
2023
Q4 | $76K | Buy |
617
+7
| +1% | +$874 | ﹤0.01% | 1916 |
|
|
2023
Q3 | $79K | Buy |
610
+20
| +3% | +$2.67K | ﹤0.01% | 1778 |
|
|
2023
Q2 | $73K | Sell |
590
-165
| -22% | -$22.2K | ﹤0.01% | 1745 |
|
|
2023
Q1 | $110K | Buy |
755
+262
| +53% | +$38.8K | ﹤0.01% | 1445 |
|
|
2022
Q4 | $79K | Sell |
493
-160
| -25% | -$23.4K | ﹤0.01% | 1488 |
|
|
2022
Q3 | $87K | Buy |
653
+217
| +50% | +$33K | ﹤0.01% | 1398 |
|
|
2022
Q2 | $68K | Buy |
436
+14
| +3% | +$2.15K | ﹤0.01% | 1480 |
|
|
2022
Q1 | $66K | Buy |
422
+85
| +25% | +$12.3K | ﹤0.01% | 1481 |
|
|
2021
Q4 | $43K | Buy |
+337
| New | +$44.3K | ﹤0.01% | 1639 |
|
|
2021
Q2 | $61K | Hold |
341
| – | – | ﹤0.01% | 1318 |
|
|
2021
Q1 | $61K | Hold |
341
| – | – | ﹤0.01% | 1318 |
|
|
2020
Q4 | $61K | Hold |
341
| – | – | ﹤0.01% | 1318 |
|
|
2020
Q3 | $61K | Hold |
341
| – | – | ﹤0.01% | 1318 |
|
|
2020
Q2 | $61K | Hold |
341
| – | – | ﹤0.01% | 1318 |
|
|
2020
Q1 | $61K | Hold |
341
| – | – | ﹤0.01% | 1318 |
|
|
2019
Q4 | $61K | Hold |
341
| – | – | ﹤0.01% | 1318 |
|
|
2019
Q3 | $61K | Hold |
341
| – | – | ﹤0.01% | 1318 |
|
|
2019
Q2 | $61K | Hold |
341
| – | – | ﹤0.01% | 1318 |
|
|
2019
Q1 | $61K | Buy |
341
+251
| +279% | +$32.7K | ﹤0.01% | 1318 |
|
|
2018
Q4 | $11K | Hold |
90
| – | – | ﹤0.01% | 1304 |
|
|
2018
Q3 | $15K | Hold |
90
| – | – | ﹤0.01% | 1036 |
|
|
2018
Q2 | $16K | Hold |
90
| – | – | ﹤0.01% | 885 |
|
|
2018
Q1 | $14K | Sell |
90
-29
| -24% | -$4.25K | ﹤0.01% | 779 |
|
|
2017
Q4 | $16K | Hold |
119
| – | – | ﹤0.01% | 750 |
|
|
2017
Q3 | $17K | Buy |
+119
| New | +$18K | ﹤0.01% | 749 |
|
Other funds holding JAZZ
VPM
VCM
EC
Carson Wealth (CWM LLC)'s JAZZ Position: Q1 2026 in Review
Carson Wealth (CWM LLC) increased its Jazz Pharmaceuticals (JAZZ) stake by 99% in Q1 2026, buying an estimated $886K and bringing the position to 10,171 shares worth $1.92M. The position accounts for 0.01% of the portfolio, ranked #1215.
Carson Wealth (CWM LLC) first reported a position in JAZZ in Q3 2017 and has held it in 34 quarters since. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.
- Carson Wealth (CWM LLC) held 10,171 shares of Jazz Pharmaceuticals worth $1.92M as of Q1 2026.
- Carson Wealth (CWM LLC) bought 5,071 Jazz Pharmaceuticals shares in Q1 2026, an estimated $886K.
- Jazz Pharmaceuticals made up 0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #1215 holding.
- Carson Wealth (CWM LLC) first reported a position in Jazz Pharmaceuticals in Q3 2017 and has held it in 34 quarters since.
- 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.
Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.